U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Biopsy, and Tissue Screening Products
WEST HARTFORD, Conn., April 10, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Biopsy, and Tissue Screening Products" at GIIResearch.com
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages.
In 2012, approximately 92.0 million oncology-related diagnostic ultrasound, minimally invasive biopsy, and tissue screening procedures were performed in the U.S. Together, these procedures generated approximately $1.1 billion in corresponding product sales; it is expected that during the forecast period covered by this report, sales of diagnostic ultrasound, minimally invasive biopsy, and tissue screening products for oncology-related indications will increase at a compound annual rate of 3.9%, reaching nearly $1.4 billion in the year 2017.
This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.
Table of Contents
- CANCER STATISTICS UPDATE
- U.S. MARKETS FOR ONCOLOGY-RELATED DIAGNOSTIC ULTRASOUND, MINIMALLY INVASIVE BIOPSY, AND TISSUE SCREENING PRODUCTS
- COMPANY PROFILES
APPENDIX: COMPANY LISTING
More detailed information is available at
Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, USfirstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.